<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="151346">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01901289</url>
  </required_header>
  <id_info>
    <org_study_id>12-004</org_study_id>
    <nct_id>NCT01901289</nct_id>
  </id_info>
  <brief_title>Zilver® PTX® V Clinical Study</brief_title>
  <official_title>Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cook</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Zilver® PTX® V Clinical Study is a post-market clinical trial required by the US FDA to
      provide continued evaluation of the safety and effectiveness of the Zilver PTX Drug-Eluting
      Peripheral Stent in treatment of narrowing of the femoropopliteal arteries.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">April 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Occurrence of target lesion revascularization (TLR).</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularization (TLR)</measure>
    <time_frame>annually through five years post-procedure.</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Integrity</measure>
    <time_frame>one, three, and five years post-procedure.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis</measure>
    <time_frame>annually through five years post-procedure.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <arm_group>
    <arm_group_label>Drug-Eluting Stent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Zilver® PTX® Drug-Eluting Peripheral Stent</intervention_name>
    <description>Treatment of symptomatic vascular disease of the native above-the-knee femoropopliteal arteries.</description>
    <arm_group_label>Drug-Eluting Stent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient has signed and dated the informed consent.

          -  Patient has symptomatic vascular disease of the native above-the-knee femoropopliteal
             arteries.

          -  Patient agrees to return for the required follow-up assessments.

        Exclusion Criteria:

          -  Patient is &lt; 18 years of age.

          -  Patient has significant stenosis of inflow tract not successfully treated before this
             procedure.

          -  Patient lacks at least one patent vessel of runoff with &lt; 50% stenosis throughout its
             course.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anthony J Battisti, Ph. D.</last_name>
    <phone>765-463-7537</phone>
    <email>tjbattisti@medinst.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University Medical School</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason Lee, MD</last_name>
      <phone>650-724-8292</phone>
      <email>jtlee@stanford.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yale New Haven School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nelson Bernardo, MD</last_name>
      <phone>202-877-5975</phone>
      <email>nelson.l.bernardo@medstar.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Feezor, MD</last_name>
      <phone>352-273-7020</phone>
      <email>Robert.feezor@surgery.ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Cardiac and Vascular Institute</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arthur Lee, MD</last_name>
      <phone>352-331-8570</phone>
      <email>leeivc@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>First Coast Cardiovascular Institute</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yazan Khatib, MD</last_name>
      <phone>904-493-3333</phone>
      <email>ykhatib@firstcoastcardio.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Genesis Health System</name>
      <address>
        <city>Davenport</city>
        <state>Iowa</state>
        <zip>52803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Bayview Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mahmoud Malas, MD</last_name>
      <phone>410-550-5332</phone>
      <email>bmalas1@jhmi.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allen Hamdan, MD</last_name>
      <phone>617-632-9953</phone>
      <email>ahamdan@BIDMC.harvard.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evan Lipsitz, MD</last_name>
      <phone>718-920-2016</phone>
      <email>elipsitz@montefiore.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>New York-Presbyterian/ Weill Cornell Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Darren Schneider, MD</last_name>
      <phone>212-746-5192</phone>
      <email>dbs9003@med.cornell.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas J Morrissey, MD</last_name>
      <phone>212-342-2929</phone>
      <email>njm2106@columbia.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>OhioHealth Research Institute</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gary Ansel, MD</last_name>
      <phone>614-262-6772</phone>
      <email>GANSEL2@OhioHealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Toledo Medical Center</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43614</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Burket, MD</last_name>
      <phone>419-383-4087</phone>
      <email>mark.burket@utoledo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Holy Spirit Hospital</name>
      <address>
        <city>Camp Hill</city>
        <state>Pennsylvania</state>
        <zip>17011</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rajesh Dave, MD</last_name>
      <phone>717-724-6304</phone>
      <email>rdintervention@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>South Carolina Heart Center</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Hall, MD</last_name>
      <phone>803-355-2927</phone>
      <email>paxhall@earthlink.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Greenville Hospital System</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29615</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruce Gray, DO</last_name>
      <phone>864-455-9833</phone>
      <email>bhgray@ghs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Holston Valley Hospital</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Metzger</last_name>
      <phone>423-230-5640</phone>
      <email>research@mycva.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 30, 2014</lastchanged_date>
  <firstreceived_date>July 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Peripheral Vascular Disease</keyword>
  <keyword>Femoral Artery</keyword>
  <keyword>Popliteal Artery</keyword>
  <keyword>Drug-Eluting Stent</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
